Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection

被引：3
|
作者：
Mori, T [1 ]
Okamoto, S
Watanabe, R
Yamazaki, R
Tsukada, Y
Nagayama, H
Ishida, A
Ikeda, Y
机构：
[1] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan
[2] Keio Univ, Sch Med, Ctr Blood, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷 / 12期
关键词：
D O I：
10.1038/sj.bmt.1703588
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1005 / 1006
页数：2
相关论文
共 50 条
  • [1] Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
    T Mori
    S Okamoto
    R Watanabe
    R Yamazaki
    Y Tsukada
    H Nagayama
    A Ishida
    Y Ikeda
    [J]. Bone Marrow Transplantation, 2002, 29 : 1005 - 1006
  • [2] Effect of Cytomegalovirus (CMV) Serostatus on the Incidence and Virological Features of Active CMV Infection in Allogeneic Stem Cell Transplant Recipients
    Solano, Carlos
    Tormo, Nuria
    de la Camara, Rafael
    Bartolo Nieto, Jose
    Lopez, Javier
    Benet, Isabel
    Munoz-Cobo, Beatriz
    Costa, Elisa
    Jose Remigia, Maria
    Garcia-Noblejas, Ana
    Bravo, Dayana
    Navarro, David
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (03) : 313 - 315
  • [3] Effect of Cytomegalovirus (CMV) Serostatus on the Incidence and Virological Features of Active CMV Infection in Allogeneic Stem Cell Transplant Recipients Reply
    Pietersma, Floor L.
    van Baarle, Debbie
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 53 (03) : 315 - 316
  • [4] Cytomegalovirus (CMV) infection in allogeneic non-myeloablative stem cell transplantation recipients
    Chandrasekar, P
    King, R
    Dansey, R
    Akhtar, A
    Mellon-Reppen, S
    Alangaden, G
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 43 - 43
  • [5] Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease
    Bordon, V.
    Bravo, S.
    Van Renterghem, L.
    de Moerloose, B.
    Benoit, Y.
    Laureys, G.
    Dhooge, C.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (01) : 19 - 23
  • [6] Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infection
    Douglas, Genevieve
    Yong, Michelle K.
    Tio, Shio Yen
    Chau, Maggie
    Prabahran, Ashvind
    Sasadeusz, Joe
    Slavin, Monica
    Ritchie, David
    Chee, Lynette
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [7] Relationship between HLA alleles and Cytomegalovirus (CMV) infection in hematopoietic stem cell transplant recipients
    Chen, Y
    Rocha, V
    Bittencourt, H
    Scieux, C
    Loiseau, P
    Chevret, S
    Charron, D
    Esperou, H
    Devergie, A
    Guardiola, P
    Socie, G
    Gluckman, E
    Ribaud, P
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S52 - S52
  • [8] LETERMOVIR FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN ADULT CMV-SEROPOSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Duarte, R.
    Marty, F.
    Ljungman, P.
    Chemaly, R.
    Maertens, J.
    Snydman, D.
    Blumberg, E.
    Einsele, H.
    Boeckh, M.
    Teal, V.
    Wan, H.
    Kartsonis, N.
    Leavitt, R.
    Badshah, C.
    [J]. HAEMATOLOGICA, 2017, 102 : 331 - 332
  • [9] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [10] THE EFFECT OF DONOR CMV SEROSTATUS ON CMV INFECTION AND OUTCOME IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS
    Green, J. S.
    Mulroney, C. M.
    Curtin, P. T.
    Taplitz, R. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S234 - S235
12345